Empirical Wealth Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-11,138
Closed -$193K 1073
2026
Q1
$193K Sell
11,138
-750
-6% -$14.2K ﹤0.01% 953
2025
Q4
$224K Sell
11,888
-1,175
-9% -$19.7K ﹤0.01% 814
2025
Q3
$190K Hold
13,063
﹤0.01% 769
2025
Q2
$255K Hold
13,063
0.01% 575
2025
Q1
$232K Sell
13,063
-100
-0.8% -$2.15K 0.01% 573
2024
Q4
$282K Sell
13,163
-500
-4% -$12.2K 0.01% 515
2024
Q3
$427K Sell
13,663
-14,500
-51% -$361K 0.01% 397
2024
Q2
$437K Hold
28,163
0.01% 390
2024
Q1
$298K Hold
28,163
0.01% 441
2023
Q4
$338K Hold
28,163
0.01% 377
2023
Q3
$197K Hold
28,163
0.01% 447
2023
Q2
$239K Buy
+28,163
New +$235K 0.01% 409
2021
Q2
Sell
-28,476
Closed -$1.94M 445
2021
Q1
$1.94M Sell
28,476
-1,572
-5% -$122K 0.16% 98
2020
Q4
$2.18M Sell
30,048
-20,610
-41% -$1.19M 0.17% 88
2020
Q3
$1.92M Buy
+50,658
New +$1.71M 0.16% 91

Other funds holding CDNA

Empirical Wealth Management's CDNA Position: Q2 2026 in Review

Empirical Wealth Management sold out of CareDx (CDNA) in Q2 2026, closing a stake of 11,138 shares — an estimated $193K sold.

Empirical Wealth Management first reported a position in CDNA in Q3 2020 and held it in 15 quarters. The position peaked at $2.18M in Q4 2020. 36 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • Empirical Wealth Management reported no remaining CareDx position as of Q2 2026 after selling out during the quarter.
  • Empirical Wealth Management sold 11,138 CareDx shares in Q2 2026, an estimated $193K.
  • Empirical Wealth Management first reported a position in CareDx in Q3 2020 and held it in 15 quarters.
  • Empirical Wealth Management's CareDx position peaked at $2.18M in Q4 2020.
  • 36 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Empirical Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.